■ 英語タイトル：Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY012 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：139 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:
The global biotechnology reagents market size reached US$ 78,719 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 126,677 Million by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2023-2028. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.

Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.

Biotechnology Reagents Market Trends:
The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on technology and application.

Technology Insights:
Life Science Reagents
PCR
Cell Culture
Hematology
In-Vitro Diagnostics
Others
Analytical Reagents
Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Others

A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).

Application Insights:
Protein Synthesis and Purification
Gene Expression
DNA and RNA Analysis
Drug Testing
Others

A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.

Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Market Overview:The global biotechnology reagents market size reached US$ 78,719 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 126,677 Million by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2023-2028. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.

Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.

Biotechnology Reagents Market Trends:
The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on technology and application.

Technology Insights:

Life Science Reagents
PCR
Cell Culture
Hematology
In-Vitro Diagnostics
Others
Analytical Reagents
Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Others

A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).

Application Insights:

Protein Synthesis and Purification
Gene Expression
DNA and RNA Analysis
Drug Testing
Others

A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

Key Questions Answered in This Report:
How has the global biotechnology reagents market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global biotechnology reagents market?
What is the impact of each driver, restraint, and opportunity on the global biotechnology reagents market?
What are the key regional markets?
Which countries represent the most attractive biotechnology reagents market?
What is the breakup of the market based on technology?
Which is the most attractive technology in the biotechnology reagents market?
What is the breakup of the market based on the application?
Which is the most attractive application in the biotechnology reagents market?
What is the competitive structure of the global biotechnology reagents market?
Who are the key players/companies in the global biotechnology reagents market?